Jakub Zmajkovic

University of Basel — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index584citations38works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(13), Advanced biosensing and bioanalysis techniques(10), RNA Interference and Gene Delivery(10), Acute Myeloid Leukemia Research(7), Myeloproliferative Neoplasms: Diagnosis and Treatment(6)

Publications38 total

Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate
Cell Reports·2024· 5 citedOpen Access
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity
Journal of Medicinal Chemistry·2024· 17 citedOpen Access
Abstract 255: Redefining SOX2 as a bifunctional mediator of transcription and adjusted translation control
Cancer Research·2024
Author Response: Precision RNAi using synthetic shRNAmir target sites
2023Open Access
Precision RNAi using synthetic shRNAmir target sites
eLife·2023· 3 citedOpen Access
Precision RNAi using synthetic shRNAmir target sites
2023Open Access
Author Response: Precision RNAi using synthetic shRNAmir target sites
2023Open Access
Data from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S5 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S2 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S3 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S1 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Data from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S4 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S1 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S3 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S2 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Table S4 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Supplementary Figures and Legends from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
Supplementary Figures and Legends from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Radek C. Skoda(23), Yuxuan Liu(15), Yuannyu Zhang(15), Alpaslan Tasdogan(15), Mingyi Chen(15), Le Qi(15), Xin Liu(15), Kailong Li(15), Junhua Lyu(15), Kathryn E. Dickerson(15), Weina Chen(15), Matthew E. Merritt(15), Sean J. Morrison(15), Ralph J. DeBerardinis(15), Jian Xu(15), Feng Cai(14), McKenzie Patrick(14), Hui Cao(14), Min Ni(14), Thomas Hoffmann(10)